"Evidence-Based Vaccine Communications in Clinical (and Population) Settings" 

Speaker:

Saad B. Omer, M.B.B.S., M.P.H., Ph.D.
Professor & Dean
Peter O'Donnell Jr. School of Public Health
UT Southwestern Medical Center

About Saad Omer:

Dr. Omer received his medical education from Aga Khan University in Pakistan. He then obtained a master's degree in public health from Johns Hopkins University, where he also completed his doctorate.

Dr. Omer has conducted studies in the United States, Guatemala, Kenya, Uganda, Ethiopia, India, Pakistan, Bangladesh, South Africa, and Australia. His research portfolio includes epidemiology of respiratory viruses such as influenza, RSV, and COVID-19; clinical trials to estimate efficacy of maternal and/or infant influenza, pertussis, polio, measles and pneumococcal vaccines; and trials to evaluate drug regimens to reduce mother-to-child transmission of HIV. Moreover, he has conducted several studies on interventions to increase immunization coverage and acceptance.

A prolific and impactful researcher, he has published more than 430 peer-reviewed papers that have been cumulatively cited more than 150,000 times. Dr Omer’s published work, which includes The New England Journal of Medicine, JAMA, Lancet, Cell, Science, and Nature, is consistently cited for policy recommendations and has informed legislative policy and clinical practice in many countries.

He has served on advisory panels including the U.S. National Vaccine Advisory Committee, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria-Vaccine Innovation Working Group, several high-level World Health Organization advisory committees, multiple National Academy of Medicine expert panels, the boards of the Sabin Vaccine Institute and Gavi, The Vaccine Alliance, and as an academic affiliate of the Office of Evaluation Sciences – formerly known as the White House Social and Behavioral Sciences Team. He has received multiple awards, including the Maurice Hilleman Award by the National Foundation for Infectious Diseases for his work on the impact of maternal influenza immunization on respiratory illness in infants younger than 6 months for whom there is no vaccine.